.24c Australian is equal to .18c American. Multiply by 20 for BNTC conversion, and we should be at $3.60 American. I believe it will retrace up, but given the volume, it may not be quite that much. I personally did not expect a lot with this announcement since applying for Orphan Designation is not the same as getting it. It really is a shame though. It could be assumed that seemingly placing HBV on the back-burner and focusing on AMD and OPMD could be viewed, albeit short-sightedly, as uncertainty to where the conpany’s own pipeline is going. But then HBV re-emerges in the quarterly call.
We just need to keep making progress, and not be discouraged. We are already more than double the sp than where we were a few months back.
Just my personal view, folks.
- Forums
- ASX - By Stock
- BLT
- Ann: OPMD Orphan Disease Program Update
Ann: OPMD Orphan Disease Program Update, page-15
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online